A carregar...
CMET-36. BEVACIZUMAB WITH OR WITHOUT LOMUSTINE FOR METASTATIC ORBITAL, DURAL AND LEPTOMENINGEAL ESTHESIONEUROBLASTOMA
Esthesioneuroblastoma is a malignant neuroectodermal tumor originating from the olfactory neuroepithelium. Bevacizumab is a specific inhibitor of the vascular endothelial growth factor ligand, preventing its interaction with receptors on endothelial cells. Lomustine is a widely used alkylating agent...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216982/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.246 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|